• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2001 - 2015年西澳大利亚州心房颤动首次住院后的非计划30天再入院、合并症及其对死亡率的影响

Unplanned 30-day readmission, comorbidity, and impact on mortality after incident atrial fibrillation hospitalization in Western Australia, 2001-2015.

作者信息

Weber Courtney, Hung Joseph, Hickling Siobhan, Li Ian, Murray Kevin, Briffa Tom

机构信息

School of Population and Global Health, University of Western Australia, Crawley, Australia.

Medical School, Faculty of Medicine and Health Sciences, University of Western Australia, Crawley, Australia.

出版信息

Heart Rhythm O2. 2022 Jun 16;3(5):511-519. doi: 10.1016/j.hroo.2022.06.002. eCollection 2022 Oct.

DOI:10.1016/j.hroo.2022.06.002
PMID:36340485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9626741/
Abstract

BACKGROUND

The healthcare burden of atrial fibrillation (AF) is dominated by hospitalizations, but data on 30-day unplanned readmissions after AF hospitalization and impact on mortality are limited.

OBJECTIVE

To assess causes and trends of 30-day unplanned readmission in incident (first-ever) hospitalized AF patients, and the risk of readmission for subsequent all-cause mortality.

METHODS

Patients aged 25-94 years, with an incident AF hospitalization (principal diagnosis) between 2001 and 2015, and surviving 30 days post discharge, were identified from linked Western Australian hospitalization and mortality data. Unplanned 30-day readmissions were categorized by principal diagnosis. Multivariable logistic and Cox regression analyses determined the independent predictors of readmission and the hazard ratio (HR) with 95% confidence intervals (CI) of readmission for subsequent 1-year mortality.

RESULTS

Of 22,814 patients, 57.7% male, mean age 67.8 ± 13.8 (standard deviation) years, 9.5% experienced 1 or more 30-day unplanned readmissions, with standardized rates increasing 2.0% annually (95% CI, 1.0%-3.1%). Among all readmissions, 64.8% were cardiovascular-related, with AF (31.7%), coronary events (12.2%), and heart failure (8.5%) being the most frequent. In 30-day survivors, 4.3% died within 1 year. Patients with any cardiovascular or noncardiovascular readmission (vs none) had a multivariable-adjusted mortality HR of 2.12 (95% CI, 1.82-2.45). Coexistent comorbidities were independently associated with 30-day unplanned readmission and 1-year mortality.

CONCLUSION

Following incident AF hospitalization, 30-day unplanned readmissions were common, mostly cardiovascular-related, but any readmission, regardless of cause, was associated with a 2-fold higher adjusted mortality risk. Our findings also support the importance of comorbidity optimization within an integrated care pathway to reduce adverse outcomes in AF patients.

摘要

背景

心房颤动(AF)的医疗负担以住院治疗为主,但关于AF住院后30天内非计划再入院情况及其对死亡率影响的数据有限。

目的

评估首次住院的AF患者30天内非计划再入院的原因和趋势,以及再入院导致后续全因死亡的风险。

方法

从西澳大利亚州住院与死亡率关联数据中识别出年龄在25至94岁之间、在2001年至2015年间有首次AF住院(主要诊断)且出院后存活30天的患者。非计划30天再入院按主要诊断分类。多变量逻辑回归和Cox回归分析确定再入院的独立预测因素以及再入院对后续1年死亡率的风险比(HR)和95%置信区间(CI)。

结果

在22814例患者中,男性占57.7%,平均年龄67.8±13.8(标准差)岁,9.5%经历了1次或更多次30天非计划再入院,标准化率每年增加2.0%(95%CI,1.0%-3.1%)。在所有再入院病例中,64.8%与心血管相关,其中AF(31.7%)、冠状动脉事件(12.2%)和心力衰竭(8.5%)最为常见。在30天存活者中,4.3%在1年内死亡。有任何心血管或非心血管再入院的患者(与无再入院患者相比)多变量调整后的死亡HR为2.12(95%CI,1.82-2.45)。共存的合并症与30天非计划再入院和1年死亡率独立相关。

结论

首次AF住院后,30天非计划再入院很常见,大多与心血管相关,但任何原因的再入院,无论其原因如何,都与调整后死亡率风险高出2倍相关。我们的研究结果还支持在综合护理路径中优化合并症管理以降低AF患者不良结局的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/2fce5675e466/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/973107049853/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/701ba7cd9f1a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/874e39daa912/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/a1d7f3991909/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/2fce5675e466/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/973107049853/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/701ba7cd9f1a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/874e39daa912/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/a1d7f3991909/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11aa/9626741/2fce5675e466/gr4.jpg

相似文献

1
Unplanned 30-day readmission, comorbidity, and impact on mortality after incident atrial fibrillation hospitalization in Western Australia, 2001-2015.2001 - 2015年西澳大利亚州心房颤动首次住院后的非计划30天再入院、合并症及其对死亡率的影响
Heart Rhythm O2. 2022 Jun 16;3(5):511-519. doi: 10.1016/j.hroo.2022.06.002. eCollection 2022 Oct.
2
Unplanned 30-day readmissions, comorbidity and impact on one-year mortality following incident heart failure hospitalisation in Western Australia, 2001-2015.2001-2015 年澳大利亚西部因心力衰竭入院的患者中,30 天内非计划性再入院、合并症及对一年死亡率的影响。
BMC Cardiovasc Disord. 2023 Jan 16;23(1):25. doi: 10.1186/s12872-022-03020-x.
3
Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.急性再入院与阵发心房颤动住院后长期死亡风险
Heart. 2023 Feb 14;109(5):380-387. doi: 10.1136/heartjnl-2022-321560.
4
Unplanned Readmissions and Long-Term Mortality Risk After Incident Heart Failure Hospitalisation in Western Australia, 2001-2015.2001-2015 年澳大利亚西部因心力衰竭入院后的非计划性再入院和长期死亡风险。
Heart Lung Circ. 2023 Aug;32(8):958-967. doi: 10.1016/j.hlc.2023.04.297. Epub 2023 Jun 2.
5
Thirty-Day Unplanned Readmissions Following Hospitalisation for Atrial Fibrillation in Australia and New Zealand.澳大利亚和新西兰因心房颤动住院治疗后的 30 天非计划性再入院情况。
Heart Lung Circ. 2022 Jul;31(7):944-953. doi: 10.1016/j.hlc.2022.02.006. Epub 2022 Mar 10.
6
Early (0-7 day) and late (8-30 day) readmission predictors in acute coronary syndrome, atrial fibrillation, and congestive heart failure patients.急性冠状动脉综合征、心房颤动和充血性心力衰竭患者的早期(0-7 天)和晚期(8-30 天)再入院预测因素。
Hosp Pract (1995). 2021 Dec;49(5):364-370. doi: 10.1080/21548331.2021.1976558. Epub 2021 Sep 12.
7
Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010.1995 - 2010年西澳大利亚州心房颤动住院发病率、患病率及相关死亡率的趋势
Int J Cardiol. 2016 Apr 1;208:19-25. doi: 10.1016/j.ijcard.2016.01.196. Epub 2016 Jan 28.
8
Long-Term Pattern and Associated Costs of Re-hospitalisations in Patients After Index Atrial Fibrillation Admission in Western Australia, 2011-2017.2011 - 2017年西澳大利亚州初次房颤入院患者再入院的长期模式及相关费用
Heart Lung Circ. 2024 Jan;33(1):55-64. doi: 10.1016/j.hlc.2023.12.004. Epub 2023 Dec 29.
9
Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data.心力衰竭住院后 30 天再入院的趋势、原因和时间:基于人群的 11 年数据分析及数据关联
Int J Cardiol. 2017 Dec 1;248:246-251. doi: 10.1016/j.ijcard.2017.07.094. Epub 2017 Aug 4.
10
Insights into hospital readmission patterns of atrial fibrillation patients.探讨心房颤动患者的住院再入院模式。
Eur J Cardiovasc Nurs. 2020 Aug;19(6):545-550. doi: 10.1177/1474515120911607. Epub 2020 Mar 9.

引用本文的文献

1
Hospital Utilization and Mortality Post-electrical Cardioversion in Patients With Atrial Fibrillation in a Community Hospital.社区医院房颤患者电复律后的住院情况及死亡率
Cureus. 2024 Aug 15;16(8):e66919. doi: 10.7759/cureus.66919. eCollection 2024 Aug.

本文引用的文献

1
Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.评估导管消融或抗心律失常药物作为心房颤动一线治疗的选择:一项随机临床试验的荟萃分析。
JAMA Cardiol. 2021 Jun 1;6(6):697-705. doi: 10.1001/jamacardio.2021.0852.
2
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.心房颤动患者住院中新发心力衰竭的发生率、预测因素和死亡风险。
Heart. 2021 Aug;107(16):1320-1326. doi: 10.1136/heartjnl-2020-318648. Epub 2021 Mar 11.
3
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.
欧洲心房颤动患者结局与 ABC(心房颤动更好护理)路径依从性护理的关系:ESC-EHRA EORP 心房颤动一般长期(AFGen LT)登记处的分析。
Europace. 2021 Feb 5;23(2):174-183. doi: 10.1093/europace/euaa274.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
Differences in stroke risk and cardiovascular mortality for Aboriginal and other Australian patients with atrial fibrillation.澳大利亚原住民和其他族裔心房颤动患者的中风风险和心血管死亡率差异。
Med J Aust. 2020 Mar;212(5):215-221. doi: 10.5694/mja2.50496. Epub 2020 Feb 6.
6
Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations.房颤住院患者再入院的结局和资源利用情况。
J Am Heart Assoc. 2019 Oct;8(19):e013026. doi: 10.1161/JAHA.119.013026. Epub 2019 Sep 19.
7
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.台湾新诊断房颤患者口服抗凝药使用情况及结局的演变性变化
Circulation. 2018 Oct 2;138(14):1485-1487. doi: 10.1161/CIRCULATIONAHA.118.036046.
8
Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000-2013.2000-2013 年澳大利亚西部非瓣膜性心房颤动住院趋势的驱动因素。
Int J Cardiol. 2019 Feb 1;276:273-277. doi: 10.1016/j.ijcard.2018.09.047. Epub 2018 Sep 13.
9
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018.澳大利亚国家心脏基金会以及澳大利亚和新西兰心脏学会:《2018年澳大利亚心房颤动诊断与管理临床指南》
Heart Lung Circ. 2018 Oct;27(10):1209-1266. doi: 10.1016/j.hlc.2018.06.1043.
10
Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort.房颤中的多种合并症和共病及其对生存的影响:来自英国生物库队列的研究结果。
Europace. 2018 Nov 1;20(FI_3):f329-f336. doi: 10.1093/europace/eux322.